期刊文献+

血清维生素D3水平与糖尿病肾病相关性研究 被引量:1

To research the correlation between Serum vitamin D3 level and the diabetes nephropathy
原文传递
导出
摘要 目的:探讨血清1,25—二羟维生素D3水平与糖尿病肾病(DN)发生发展的相关性。方法:根据479例2型糖尿病患者(T2DM)的尿微量白蛋白肌酐比值,将糖尿病患者分为糖尿病正常蛋白尿组(DM组),糖尿病肾病早期组(EDN组)和糖尿病肾病临床期组(CDN组)。检测各组血清1,25—二羟维生素D3、血糖、血脂、血清肌酐、尿素水平;以181例健康检查者为正常对照组(NC组)。结果:①T2DM各组血清1,25—二羟维生素D3水平均明显低于NC组,T2DM各组间血清1,25—二羟维生素D3水平有明显差异(P<0.05)。②血清1,25—二羟维生素D3水平与血清肌酐(Cr)、尿酸(UA)、胱抑素c(Cysc)、β2-微球蛋白(β2-MG)、甘油三酯(TG)、总胆固醇(TC)、脂蛋白a(Lpa)负相关(P<0.05)。结论:T2DM患者血清1,25—二羟维生素D3水平随着尿微量白蛋白肌酐比值的增加而降低,可能与DN的进展有关。 Objective :To explore the correlation of serum 1, 25 dihydroxy vitamin D3 in the development of type 2 diabetes mellitus and diabetic nephropathy. Method: 479 patients with type 2 diabetes mellltus. According to urinary albumin to creatinine ratio(ACR), the patients with type 2 diabetes mellitus were divided into normal albuminuria diabetic group (DM), diabetic nephropathy early group (EDN group) and the diabetes nephropathy clinical period group (CDN group). Levels of serum 1, 25 - dihydroxyl vitamin D3, glucose, lipid, creatinine, urea were measured. 81 healthy individuals were normal controls. Results: ① Serum 1, 25 - dihydroxyl vitamin D3 levels in T2DM groups were lower than that of normal controls. Serum 1, 25 - dihydroxyl vitamin 133 levels in every group of T2DM was significant difference(P〈0.05). ② Serum 1, 25 - dihydroxyl vitamin D3 levels were negatively correlated with creatinine, urea, eystatin c, 132- MG, TG, TC, Lpa (P〈 0.05). Conclusions: Serum 1, 25 - dihydroxyl vitamin D3 levels in T2DM groups were decreased along with the increase of 1, 25 - dihydroxyl vitamin 133 Along with the increase of ACR may be related to important of DN.
出处 《微量元素与健康研究》 CAS 2013年第5期8-10,共3页 Studies of Trace Elements and Health
基金 贵州省卫生厅科学技术基金项目GZWKJ2012-1-130
关键词 1 25—二羟维生素D3 2型糖尿病 糖尿病肾病 1, 25 - dihydroxyl vitamin D3 type 2 diabetes mellitus diabetic nephropathy
  • 相关文献

参考文献15

  • 1Deb DK, Chen YZ, Li YC, et al. 1,25 - dihydroxy vitamin 133 suppresses high glucose - induced angiotensinogen expression in kidney cells by blocking the NF- kappa B pathway[J ]. American Journal of Physiology - Renalphysiology,2009,296(5) : 1212 - 1218.
  • 2Marghetita T Cantorna, Yan Zhu, Monica Froicu, et al. Vitamin D status. 1,25 - dihvdroxv vitamin D3. and theimmune system [ J ]. Am J Clin Nutr, 2004,80 (Suppl) : 1717S- 1720S.
  • 3Li YC. Vitamin D and Diabetic Nephropathy [ J ]. Curent Diabetes Repots, 2008,8(12) :464 - 469.
  • 4Norman A W, Frankel JB, Heldt A M, et al. Vitamin D deficiency inhibits pancreatic secretion of insulin [ J ]. Science, 1980,209(4458) :823 - 825.
  • 5Oh JY, Barrett- Connor E. Assciation between vitamin D receptor polymorphism and type 2 diabetes or metabolic syndrome in community- dwelling older adults: the Rancho Bernardo Study [ J ]. Metabolism, 2002,51 (3) : 356 - 359.
  • 6Ortlepp JR, Metrikat J, Albrecht M, et al. The vitamin D receptor gene variant and physical activity predicts fasting glucose levels in healthy young men [ J ]. D;.abet Med, 2003, 20(6) :451.454.
  • 7Martin R.I, Mcknight AJ, Patterson CC, et al. A rare haplotype of the vitamin D receptor gene is protective against diabetic nephropathy [J ]. Nephrol Dial Transplant, 2010,25(2) :497. 503.
  • 8Diaz VA, Mainous ACT 3rd, Carek PJ, et al. The association of vitamin D deficiency and insufficiency with diabetic nephropathy: implications fro health disparities [J]. ,I Am Board Fam Med,2009,22(5) :521-7.
  • 9Li YC. Vitamin D and Diabetic Nephropathy [ J ]. CurentDiabetes Repots,2008,8(12) :464 - 469.
  • 10Deb DK, Chen YZ, Li YC, et al. 1, 25 - Dihydroxy vitamin D3 suppresses high glucose - induced angiotensinogen expression in kidney cells by blocking the NF- kappa B pathway [ J ]. American Journal of Physiology - Renalphysiology, 2009, 296 ( 5 ) : 1212 - 1218.

同被引文献26

  • 1Holick MF.Vitamin D deficiency[J].N Engl J Med,2007,357(3):266-281.
  • 2Hurskainen AR1,Virtanen JK,Tuomainen TP,et al.Association of serum 25-hydroxyvitamin D with type 2 diabetes and markers of insulin resistance in a general older population in Finland[J].Diabetes Metab Res Rev,2012,28(5):418-423.
  • 3Patel TV,Singh AK.Role of vitamin D in chronic kidney disease[J].Semin Nephrol,2009,29(2):113-121.
  • 4Kaseda R,Hosojima M,Sato H,et al.Role of megalin and cubilin in the metabolism of vitamin D(3)[J].Ther Apher Dial,2011,15(Suppl 1):14-17.
  • 5Joergensen C,Gall MA,Schmedes A,et al.Vitamin D levels and mortality in type 2 diabetes[J].Diabetes Care,2010,33(10):2238-2243.
  • 6Plum LA,Zella JB.Vitamin D compounds and diabetic nephropathy[J].Arch Biochem Biophys,2012,523(1):87-94.
  • 7Patel TV,Singh AK.Role of vitamin D in chronic kidney disease[J].Semin Nephrol,2009,29(2):113-121.
  • 8Kuhlmann A,Haas CS,Gross ML,et al.25-Dihydroxyvitamin D3decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat[J].Am J Physiol Renal Physiol,2004,286(3):F526-F533.
  • 9Panichi V,Migliori M,Taccola D,et al.Effects of 1,25(OH)2D3 in experimental mesangial proliferative nephritis in rats[J].Kidney Int,2001,60(1):87-95.
  • 10Takiishi T,Gysemans C,Bouillon R,et al.Vitamin D and diabetes[J].Endocrinol Metab Clin North Am,2010,39(2):419-446.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部